Sign in
Taking peopleNo phase

Cognitive Evaluation of Patients With Eating Disorders

Key facts

Who runs it
Istituti Clinici Scientifici Maugeri SpA
Where
Italy3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
84 people, planned
Started
26 Nov 2024
Expected to end
31 Mar 2028
Type of study
Observational, 3 groups
Treatments tested
  • Go/No-go
  • IAT
  • WCST
Record updated
16 April 2026

Who can take part

Age
14 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Diagnosis of a Feeding and Eating Disorder (ARFID, anorexia nervosa, or bulimia nervosa)
  • Patients of both sexes
  • Age between 14 and 65 years
  • Confirmed diagnosis of a Feeding and Eating Disorder
  • Body Mass Index (BMI) < 25
  • Signed informed consent form for participation in the study

Who cannot take part

  • Diagnosis of Bipolar Disorder according to DSM-5-TR criteria
  • Diagnosis of a Schizophrenia Spectrum Disorder according to DSM-5-TR criteria
  • History of seizure events
  • Presence of other moderate to severe neurological disorders
  • Intellectual disability according to DSM-5-TR criteria
  • Presence of brain tumors
  • Lack of the patient's consent to voluntary participation in the study
  • Lack of parental or legal guardian consent for participation of a minor in the study

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 14 and 65 years old?

This trial is currently available in Italy.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this cross - sectional observational study is to improve understanding of the psychological and cognitive characteristics of Feeding and Eating Disorders (FEDs), a group of conditions that represent a growing public health concern due to their significant impact on physical health, emotional well-being, and everyday functioning. Within this broader diagnostic category, particular attention is given to Avoidant/Restrictive Food Intake Disorder (ARFID), a diagnosis introduced in the DSM-5 and still relatively underexplored compared to other feeding and eating disorders.

Read full original descriptionShow less

Despite its clinical relevance, ARFID remains less well understood in terms of its underlying cognitive and psychological mechanisms. Individuals with ARFID often experience severe food avoidance or restriction that is not driven by weight or shape concerns, but rather by sensory sensitivities, fear of negative consequences of eating, or a lack of interest in food. For this reason, investigating ARFID can offer important insights into the diversity of mechanisms involved in feeding and eating disorders as a whole.

The study has two main objectives. The first objective is to examine the cognitive profile of individuals with ARFID, with a specific focus on autistic traits and cognitive flexibility, as previous research suggests potential overlaps between ARFID and neurodevelopmental conditions such as Autism Spectrum Disorders. Cognitive flexibility refers to the ability to adapt thoughts and behaviors in response to changing situations, and reduced flexibility may contribute to rigid eating patterns and food avoidance.

The second objective is to explore the role of body representation (how individuals perceive and mentally represent their own body) and inhibitory control (the ability to regulate or suppress automatic responses) in shaping the cognitive and behavioral features of ARFID and other feeding and eating disorders. These processes may help distinguish ARFID from other diagnoses and clarify shared and disorder-specific mechanisms across the FED spectrum.

The study involves adult participants of all genders, including individuals diagnosed with ARFID, anorexia nervosa, and bulimia nervosa, as well as healthy control participants without a history of feeding or eating disorders. This design allows meaningful comparisons between different diagnostic groups and with the general population.

The main questions the study aims to answer are:

Do individuals with ARFID show a distinct cognitive profile, particularly in terms of autistic traits and cognitive flexibility, compared to individuals with other feeding and eating disorders and healthy controls?

How do body representation and inhibitory control contribute to differences in eating-related behaviors across feeding and eating disorders?

Are there differences in brain activity associated with implicit, automatic attitudes toward food in individuals with feeding and eating disorders compared to healthy individuals?

Where comparison groups are included, researchers will compare participants with ARFID, anorexia nervosa, bulimia nervosa, and healthy controls to examine differences in cognitive functioning, psychological characteristics, and neural responses related to food processing.

Participants will be asked to take part in a series of non-invasive and well-established research activities, designed to be accessible and safe. These include:

Completing self-report questionnaires assessing autistic traits, body image perception, and general psychological well-being;

Performing computer-based tasks that assess cognitive flexibility and decision-making;

Completing behavioral tasks designed to measure inhibitory control and automatic associations with food-related stimuli;

The 3 groups in the trial

  • Healthy control

    Every participant recieve all the interventions described, each one of them with the specific randomization of subministration.

    Treatment: Go/No-go, IAT, and WCST

  • ARFID

    Patients with Avoidant Restrictive Food Intake Disorder. Every participant recieve all the interventions described, each one of them with the specific randomization of subministration.

    Treatment: Go/No-go, IAT, and WCST

  • AN/BN

    Patients with a diagnosis of Anorexia Nervosa or Bulimia Nervosa. Every participant recieve all the interventions described, each one of them with the specific randomization of subministration.

    Treatment: Go/No-go, IAT, and WCST

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Neuro-cognitive Profiles of Patients With Nutritional and Eating Disorders
Criteria questions
Built from NCT07478510, who can take part
Record updated
16 April 2026